Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

Study of Add-on Ambrisentan Therapy to Background Phosphodiesterase Type-5 Inhibitor (PDE5i) Therapy in Pulmonary Arterial Hypertension (ATHENA-1)

Gilead Sciences · 2008
ClinicalTrials.gov · Datasets · License: Public Domain · 2008
Open Source ↗
cardiovascularera
pulmonary arterial hypertension, ambrisentan, pah, combination therapy, phosphodiesterase type-5 inhibitor (pde-5i), cardiovascular, endothelin receptor antagonist, era, interventional, phase4
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 843787
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.